Back to search

Article

PREFER-DMT: A Discrete Choice Experiment Framework for Eliciting Stakeholder Preferences on Disease-Modifying Therapy Implementation in European Healthcare Systems

2026-04-14

Abstract excerpt

<title>Abstract</title> <p> <bold>Background:</bold> Health technology assessment (HTA) bodies across Europe are preparing to evaluate Alzheimer’s disease-modifying therapies (DMTs), yet no standardised framework exists for eliciting and comparing stakeholder preferences on DMT implementation across different healthcare systems. Existing discrete choice experiment (DCE) evidence on Alzheimer’s treatment prefere...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c862bab4-f5d0-5c26-badf-1b795110e0d4
DOI
10.21203/rs.3.rs-9405777/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
PREFER-DMT: A Discrete Choice Experiment Framework for Eliciting Stakeholder Preferences on Disease-Modifying Therapy Implementation in European Healthcare SystemsDOI 10.21203/rs.3.rs-9405777/v1
Select a neighboring publication to make it the new centre.